Monte Rosa Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +345.1% | +641.9% | -6.5% | -11.3% | +44.4% | +2.3% | |
| – | +346.7% | +699.9% | -20.9% | -14.4% | +59.8% | +4.2% | |
| – | +595.6% | +729.9% | -84.1% | +133.3% | +75.1% | -42.1% | |
| – | +595.6% | +729.9% | -24.1% | -11.6% | +60.1% | +1.3% | |
| – | +54.9% | – | – | -93.4% | -65.7% | +2,559.0% | |
| – | – | – | – | – | – | – | |
| – | +246.3% | +166.6% | +119.7% | – | – | – | |
| – | +322.1% | -80.8% | +277.3% | +75.4% | +73.3% | -0.1% | |
| – | +582.1% | -43.2% | +53.7% | +82.2% | +236.9% | -59.1% | |
| – | – | – | – | +1.1% | +17.5% | +18.4% | |
| – | +121.2% | -7.2% | +19.9% | +41.8% | +54.4% | -79.4% | |
| – | – | – | -21.9% | -34.0% | +24.4% | +4.5% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +5.8% | +1.5% | +8.8% | +43.8% | -11.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.